Acutus Medical, fresh off a successful first-in-human trial of its heart-mapping technology, raised $21.6 million of a hoped-for $30.6 million Series B round, founder, president & CEO Randy Werneth told MassDevice.com today.
Funding Roundup
Funding: Texas renal disease devices maker raises $9.5M
Austin, Texas, medical device maker TVA Medical landed $9.5 million in a Series B financing round in support of the company’s efforts to further validate and win regulatory approvals for its minimally invasive end-stage renal disease therapy systems.
TVA’s catheter-based endovascular technology allows physicians to join arteries to veins, forming what’s called a "fistula," in order to deliver hemodialysis to patients suffering from kidney failure.
Pain management: St. Jude pays $40M for exclusive purchase option for Spinal Modulation
St. Jude Medical (NYSE:STJ) last week branded neurostimulation devices maker Spinal Modulation as its territory with a $40 million equity investment that gives St. Jude international distribution rights and an exclusive option to acquire the company down the road.
Baxter buys stake in Ocular Therapeutix
Cheetah Medical shuffles the C-suite, raises $14.5M
Cheetah Medical shook up the C-suite this week, added a new CEO and a new medical chief – plus $14.5 million to the fluid management device maker’s coffers.
Diabetes: Valeritas lands $100M fund for insulin delivery system
Diabetes devices maker Valeritas announced today that it closed a structured debt financing with $100 million to support commercial efforts of its V-Go insulin delivery system.
The new funding adds to Valeritas’ previously raised $150 million in equity, as well as continued support from the company’s private equity and venture capital backers, the company said.
Tria Beauty raises $40M in an open-ended funding round
Cosmetic medical device company Tria Beauty Inc. has so far raised $40 million in an open-ended equity funding round, and 13 unnamed investors are contributing to the pot, according to regulatory documents.
The Pleasanton, Calif.-based company expects to wrap up the offering by 2015 with no cap on the total raised, according to company filings. Tria went public 1 year ago in an IPO underwritten by Morgan Stanley and Wells Fargo.
Report: Medical devices claim a (barely) growing sliver of U.S. healthcare spending
The U.S. is 2nd in the world in terms of per-capita medical device spending (Switzerland is 1st), but in terms of a fraction of spending medical devices account for a rather small sliver of the U.S. healthcare pie.
Medical devices made up less than 5% of total healthcare spending in the U.S. from 2006 to 2011, but the small portion that medtech did take grew modestly in that period of time, according to a report from the Canadian Health Policy Institute.
Abbott, Boston Scientific pay almost no taxes in Ireland despite billions in profits | Wall Street Beat
Mercator MedSystems raises $6.5M for Cricket, Bullfrog micro-infusion systems
Privately held Mercator MedSystems plans to launch sales of its Bullfrog and Cricket micro-infusion systems with the new $6.5 million in funding the California company raised in a Series B round.
Mercator will initiate sales in Europe, the U.S. and Australia, and will also use the funds to support clinical studies of its peripheral artery disease product platform.
Proa Medical raises $1.1M in an indefinite offering
Proa Medical raised $1.1 million in an indefinite offering of equity, options, warrants and other securities that has so far drawn 12 investors, according to a report filed with the SEC.
The Redondo Beach, Calif.-based Proa Medical, formerly called MedTools Inc., is a private company founded in 2010 by a team of physicians.